Eficur 50ml

Description

Eficur 50ml   Indications for use Infections associated with bacteria sensitive to Ceftiofur

Swine:https://bodaxvet.com/

• Treatment of bacterial respiratory disease associated with Pasteurella multocida, Actinobacillus pleuropneumoniae and Streptococcus suis.

Cattle:

• For the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histophillus somni.
• For the treatment of acute interdigital necrobacillosis (panaritium, foot rot) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus (Phorphyromonas asaccharolytica).
• For the treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving associated with Escherichia coli, Arcanobacterium pyogenes and Fusobacterium necrophorum.
• Eficur 50ml   Indications for use Infections associated with bacteria sensitive to Ceftiofur:Swine:
  • Treatment of bacterial respiratory disease associated with Pasteurella multocida, Actinobacillus pleuropneumoniae and Streptococcus suis.

  Cattle:

  • For the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histophillus somni.
  • For the treatment of acute interdigital necrobacillosis (panaritium, foot rot) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus (Phorphyromonas asaccharolytica).
  • For the treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving associated with Escherichia coli, Arcanobacterium pyogenes and Fusobacterium necrophorum.
  • Eficur 50ml   Indications for use Infections associated with bacteria sensitive to Ceftiofur:Swine:
    • Treatment of bacterial respiratory disease associated with Pasteurella multocida, Actinobacillus pleuropneumoniae and Streptococcus suis.

    Cattle:

    • For the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histophillus somni.
    • For the treatment of acute interdigital necrobacillosis (panaritium, foot rot) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus (Phorphyromonas asaccharolytica).
    • For the treatment of the bacterial component of acute post-partum (puerperal) metritis within 10 days after calving associated with Escherichia coli, Arcanobacterium pyogenes and Fusobacterium necrophorum.